The Latest Breaking News from Nasdaq

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that UroGen Pharma will report an earnings per share (EPS) of $-1.33.

Analysts have provided the following ratings for Texas Roadhouse (NASDAQ:TXRH) within the last quarter:

CareCloud, Inc (NASDAQ:MTBC) reported first-quarter FY22 revenue growth of 19% year-on-year to $35.3 million beating the consensus of $33.8 million. Adjusted EPS of $0.23 beat the consensus loss of $(0.27). CareCloud held $10.1 million in cash and equivalents and generated $3.1 million in operating cash flow. CareCloud reiterated the FY22 revenue outlook of…

Concentrix Corporation (NASDAQ:CNXC) agreed to acquire customer journey experience company ServiceSource International, Inc (NASDAQ:SREV) in an all-cash transaction of $1.50 per share.  The purchase price represents a 47% premium to ServiceSource's unaffected closing stock price on May 6. Concentrix is a leading provider of customer experience (CX) services and technologies. "We are delighted to join…

When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only certainty is that recession-proof stocks do not exist. On the other hand, recession-resistant companies are what a savvy investor searches for during the absence of a bull market, as we are now.

The Fed’s recent interest rate hike of 0.5% is the most significant in over 20 years. Chairman Jerome Powell expects several additional rate hikes through the end of 2022 and into 2023 amid the highest inflation the United States has seen since December 1981.

On Friday, shares of Hudson Technologies, Inc. (NASDAQ: HDSN) saw unusual short activity. After the short activity, the stock price moved up 2.54% to $9.29. 

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 21 strange trades.

Points.com Inc (NASDAQ:PCOM) (TSX:PTS) entered into an arrangement agreement with Plusgrade Parent L.P. to be acquired for $25 per common share in cash (equivalent to C$32.21). The transaction values Points at ~$385 million on an equity value basis. The consideration represents a 45% premium to Points' closing price on the TSX on May…

Twitter Inc (NYSE: TWTR) shares traded lower by 4% on Monday, well off the $54.20 per-share buyout price Tesla Inc (NASDAQ: TSLA) CEO Elon Musk has agreed to pay to take Twitter private.